Literature DB >> 33590946

Hallmarks of the aging T-cell system.

Huimin Zhang1,2, Cornelia M Weyand1,2, Jörg J Goronzy1,2.   

Abstract

The adaptive immune system has the enormous challenge to protect the host through the generation and differentiation of pathogen-specific short-lived effector T cells while in parallel developing long-lived memory cells to control future encounters with the same pathogen. A complex regulatory network is needed to preserve a population of naïve cells over lifetime that exhibit sufficient diversity of antigen receptors to respond to new antigens, while also sustaining immune memory. In parallel, cells need to maintain their proliferative potential and the plasticity to differentiate into different functional lineages. Initial signs of waning immune competence emerge after 50 years of age, with increasing clinical relevance in the 7th-10th decade of life. Morbidity and mortality from infections increase, as drastically exemplified by the current COVID-19 pandemic. Many vaccines, such as for the influenza virus, are poorly effective to generate protective immunity in older individuals. Age-associated changes occur at the level of the T-cell population as well as the functionality of its cellular constituents. The system highly relies on the self-renewal of naïve and memory T cells, which is robust but eventually fails. Genetic and epigenetic modifications contribute to functional differences in responsiveness and differentiation potential. To some extent, these changes arise from defective maintenance; to some, they represent successful, but not universally beneficial adaptations to the aging host. Interventions that can compensate for the age-related defects and improve immune responses in older adults are increasingly within reach.
© 2021 Federation of European Biochemical Societies.

Entities:  

Keywords:  T-cell aging; T-cell differentiation; T-cell homeostasis; adaptive immunity; cellular senescence; immunosenescence

Mesh:

Substances:

Year:  2021        PMID: 33590946      PMCID: PMC8364928          DOI: 10.1111/febs.15770

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.622


  167 in total

1.  Duration of antiviral immunity after smallpox vaccination.

Authors:  Erika Hammarlund; Matthew W Lewis; Scott G Hansen; Lisa I Strelow; Jay A Nelson; Gary J Sexton; Jon M Hanifin; Mark K Slifka
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

Review 2.  Asymmetric division and stem cell renewal without a permanent niche: lessons from lymphocytes.

Authors:  J T Chang; S L Reiner
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2008-11-06

Review 3.  The natural history of naive T cells from birth to maturity.

Authors:  Benedict Seddon; Andrew J Yates
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

4.  Dynamics of Individual T Cell Repertoires: From Cord Blood to Centenarians.

Authors:  Olga V Britanova; Mikhail Shugay; Ekaterina M Merzlyak; Dmitriy B Staroverov; Ekaterina V Putintseva; Maria A Turchaninova; Ilgar Z Mamedov; Mikhail V Pogorelyy; Dmitriy A Bolotin; Mark Izraelson; Alexey N Davydov; Evgeny S Egorov; Sofya A Kasatskaya; Denis V Rebrikov; Sergey Lukyanov; Dmitriy M Chudakov
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

5.  Immune cell repertoires in breast cancer patients after adjuvant chemotherapy.

Authors:  Claire E Gustafson; Rohit Jadhav; Wenqiang Cao; Qian Qi; Mark Pegram; Lu Tian; Cornelia M Weyand; Jorg J Goronzy
Journal:  JCI Insight       Date:  2020-02-27

Review 6.  Epigenomics of T cell activation, differentiation, and memory.

Authors:  Suresh Cuddapah; Artem Barski; Keji Zhao
Journal:  Curr Opin Immunol       Date:  2010-03-11       Impact factor: 7.486

Review 7.  Regulation of DNA double-strand break repair pathway choice.

Authors:  Meena Shrivastav; Leyma P De Haro; Jac A Nickoloff
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

8.  Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity.

Authors:  Guangjin Li; Mingcan Yu; Won-Woo Lee; Michael Tsang; Eswar Krishnan; Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Med       Date:  2012-09-30       Impact factor: 53.440

9.  Age-associated changes in human CD4+ T cells point to mitochondrial dysfunction consequent to impaired autophagy.

Authors:  Arsun Bektas; Shepherd H Schurman; Marta Gonzalez-Freire; Christopher A Dunn; Amit K Singh; Fernando Macian; Ana Maria Cuervo; Ranjan Sen; Luigi Ferrucci
Journal:  Aging (Albany NY)       Date:  2019-11-09       Impact factor: 5.682

10.  The chromatin accessibility signature of human immune aging stems from CD8+ T cells.

Authors:  Duygu Ucar; Eladio J Márquez; Cheng-Han Chung; Radu Marches; Robert J Rossi; Asli Uyar; Te-Chia Wu; Joshy George; Michael L Stitzel; A Karolina Palucka; George A Kuchel; Jacques Banchereau
Journal:  J Exp Med       Date:  2017-09-13       Impact factor: 14.307

View more
  11 in total

Review 1.  Understanding T cell aging to improve anti-viral immunity.

Authors:  Huimin Zhang; Cornelia M Weyand; Jörg J Goronzy; Claire E Gustafson
Journal:  Curr Opin Virol       Date:  2021-10-21       Impact factor: 7.090

2.  Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals.

Authors:  Norihide Jo; Rui Zhang; Hideki Ueno; Takuya Yamamoto; Daniela Weiskopf; Miki Nagao; Shinya Yamanaka; Yoko Hamazaki
Journal:  Front Aging       Date:  2021-08-10

Review 3.  Emerging cellular senescence-centric understanding of immunological aging and its potential modulation through dietary bioactive components.

Authors:  Rohit Sharma; Bhawna Diwan; Anamika Sharma; Jacek M Witkowski
Journal:  Biogerontology       Date:  2022-10-19       Impact factor: 4.284

4.  T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients.

Authors:  Harry Pickering; Joanna Schaenman; Maura Rossetti; Richard Ahn; Gemalene Sunga; Emily C Liang; Suphamai Bunnapradist; Elaine F Reed
Journal:  Hum Immunol       Date:  2022-02-18       Impact factor: 2.211

Review 5.  Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change.

Authors:  Tamas Fulop; Anis Larbi; Graham Pawelec; Alan A Cohen; Guillaume Provost; Abedelouahed Khalil; Guy Lacombe; Serafim Rodrigues; Mathieu Desroches; Katsuiku Hirokawa; Claudio Franceschi; Jacek M Witkowski
Journal:  Vaccines (Basel)       Date:  2022-04-13

Review 6.  How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19.

Authors:  Ludmila Müller; Svetlana Di Benedetto
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

Review 7.  Age as a risk factor in vasculitis.

Authors:  Andrea D Gloor; Gerald J Berry; Jorg J Goronzy; Cornelia M Weyand
Journal:  Semin Immunopathol       Date:  2022-02-09       Impact factor: 11.759

8.  Quantitative restoration of immune defense in old animals determined by naive antigen-specific CD8 T-cell numbers.

Authors:  Jennifer L Uhrlaub; Mladen Jergović; Christine M Bradshaw; Sandip Sonar; Christopher P Coplen; Jarrod Dudakov; Kristy O Murray; Marion C Lanteri; Michael P Busch; Marcel R M van den Brink; Janko Nikolich-Žugich
Journal:  Aging Cell       Date:  2022-03-15       Impact factor: 9.304

9.  Novel approach to analysis of the immune system using an ungated model of immune surface marker abundance to predict health outcomes.

Authors:  G Provost; F B Lavoie; A Larbi; T P Ng; C Tan Tze Ying; M Chua; T Fulop; A A Cohen
Journal:  Immun Ageing       Date:  2022-08-04       Impact factor: 9.701

10.  Analysis of T and NK cell subsets in the Sicilian population from young to supercentenarian: The role of age and gender.

Authors:  Mattia Emanuela Ligotti; Anna Aiello; Giulia Accardi; Stefano Aprile; Floriana Bonura; Matteo Bulati; Francesco Gervasi; Giovanni M Giammanco; Fanny Pojero; Nahid Zareian; Calogero Caruso; Farzin Farzaneh; Giuseppina Candore
Journal:  Clin Exp Immunol       Date:  2021-06-17       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.